Caitlin Lewis is the Research Director and Chair of the Board at the Longevity Escape Velocity (LEV) Foundation, a nonprofit research organisation advancing combinatorial interventions to counteract ageing. With a background in mitochondrial gene therapies at the SENS Research Foundation, she now leads LEV's flagship research programme, Robust Mouse Rejuvenation (RMR). This unprecedented pipeline investigates synergistic combinations of life and healthspan-extending interventions - such as rapamycin, senolytics, stem cell transplantation, gene therapy, albumin replacement, and more- to demonstrate the feasibility of medical interventions against aging via combined damage repair.